Document is current
Any future updates will be listed below
-
Authors
Yukishima, Toshitaka https://orcid.org/0000-0003-2265-6724
Ebina, Kosuke https://orcid.org/0000-0002-2426-1024
Etani, Yuki https://orcid.org/0000-0001-5741-5969
Noguchi, Takaaki https://orcid.org/0000-0001-9938-6780
Ohmura, Shin-ichiro https://orcid.org/0000-0001-8651-4149
Nakata, Ken https://orcid.org/0000-0002-4086-4984
Okada, Seiji https://orcid.org/0000-0002-5107-8209
Kobayakawa, Tomonori
-
Funding
Funding for this research was provided by:
Osaka University
- License Information
-
More Information
Article History
Received: 5 November 2024
Accepted: 30 December 2024
First Online: 16 January 2025
Declarations
:
: KE has received research grants from Asahi Kasei, Eisai, and Teijin Pharma and speaker fees from Amgen, Asahi Kasei, Astellas, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Ono Pharmaceutical, Pfizer, Taisho and UCB Japan. KE is affiliated with the Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, supported by Asahi Kasei. YE received research grants and/or speaker fees from Asahi Kasei, Eisai, Eli Lilly, Ono Pharmaceuticals, and Taisho. YE is affiliated with the Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, supported by Asahi Kasei. KN received a research grant from Astellas and supervises the Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, supported by Asahi Kasei. TK has received payments for lectures from AbbVie, Amgen, Asahi Kasei, Astellas, Daiichi Sankyo, Eisai, Eli Lilly, Tanabe-Mitsubishi, Teijin Pharma, and Janssen Pharmaceutical K.K.. TY, TN, Shin-ichiro O, and Seiji O declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
